1. Home
  2. PMCB vs NCRA Comparison

PMCB vs NCRA Comparison

Compare PMCB & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.95

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Logo Nocera Inc.

NCRA

Nocera Inc.

HOLD

Current Price

$1.29

Market Cap

13.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMCB
NCRA
Founded
1996
2002
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
13.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PMCB
NCRA
Price
$0.95
$1.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.9M
49.7K
Earning Date
12-15-2025
04-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
N/A
$14,106,275.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$162.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.70
52 Week High
$1.90
$2.40

Technical Indicators

Market Signals
Indicator
PMCB
NCRA
Relative Strength Index (RSI) 50.52 58.51
Support Level $0.71 $0.83
Resistance Level $1.51 $0.95
Average True Range (ATR) 0.20 0.10
MACD 0.02 0.05
Stochastic Oscillator 33.08 86.00

Price Performance

Historical Comparison
PMCB
NCRA

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

Share on Social Networks: